Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Pres. Restrictions Dosage
31 Alcohol 70% Solution D08AX08-000-L99-01-XXX C+ Use as antiseptic and disinfectant - Apply to the skin undiluted or when needed
32 Alendronate Sodium 70 mg and Cholecalciferol 5600 IU Tablet M05BB03-972-T10-02-XXX A* i) Osteoporosis in postmenopausal women with a history of vertebral fracture and whom oestrogen replacement therapy is contraindicated ii) Male Osteoporosis - 1 tablet once weekly [70mg/5600 IU]. Patient should receive supplemental calcium or vitamin D, if dietary vitamin D inadequate. The tablet should be taken at least half and hour before the first food, beverage, or medication of the day with plain water only. To facilitate delivery to stomach and thus reduce the potential for esophageal irritation, it should only be swallowed upon arising for the day with a full glass of water and patient should not lie down for at least 30 minutes and until after their first food of the day.
33 Alendronate Sodium 70 mg Tablet M05BA04-520-T10-01-XXX A* i) Osteoporosis in postmenopausal women with a history of vertebral fracture and whom oestrogen replacement therapy is contraindicated. ii) Osteoporosis (Male) - 70 mg once weekly. Swallow the tablet whole with a full glass of plain water only on an empty stomach at least 30 minutes before breakfast (and any other oral medication); stand or sit upright for at least 30 minutes and do not lie down until after eating breakfast
34 Alfacalcidol 0.25 mcg Capsule A11CC03-000-C10-01-XXX A/KK i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis - Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily; CHILD under 20kg body weight : 0.05 mcg/kg/day. Maintenance dose : 0.25 mcg to 2 mcg daily
35 Alfacalcidol 1 mcg Capsule A11CC03-000-C10-02-XXX A/KK i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis - Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily; CHILD under 20kg body weight : 0.05 mcg/kg/day. Maintenance dose : 0.25 mcg to 2 mcg daily
36 Alfacalcidol 2 mcg/ml Drops A11CC03-000-D50-01-XXX A* i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis - NEONATES : 0.1 mcg/kg/day
37 Alfacalcidol 2 mcg/ml Injection A11CC03-000-P30-01-XXX A* Treatment of: i) Renal osteodystrophy in patients on haemodialysis ii) Hypoparathyroidism and pseudohypoparathyroidism iii) Adjunct to the management of tertiary hyperparathyroidism iv) Rickets and osteomalacia v) Osteoporosis - Adult: Initially, 1 mcg daily. Maintenance: 0.25-1 mcg daily. Child: Premature infants and neonates: 0.05-0.1 mcg/kg daily; <20 kg: 0.05 mcg/kg daily. Elderly: 0.5 mcg daily.
38 Alfentanil HCl 0.5 mg/ml Injection N01AH02-110-P30-01-XXX A* For use as short acting narcotic analgesic in short procedures and day-care surgical procedures - Initial dose: 20 - 40 mcg/kg. Supplemental dose: 15 mcg/kg or infusion 0.5 - 1.0 mcg/kg/min
39 Alfuzosin HCl 10 mg Tablet G04CA01-110-T10-01-XXX A* Treatment of functional symptoms related with benign prostatic hypertrophy (BPH) - 10 mg once a day pre bed
40 Alglucosidase alfa 5 mg/ml Injection A16AB07-000-P40-01-XXX A* Infantile-onset Pompe disease - 20 mg/kg of body weight administered once every 2 weeks as an intravenous infusion. Monitoring It is suggested that patients be monitored periodically for IgG antibody formation. Patients who experience Infusion-associated reactions suggestive of hypersensitivity may be tested for IgE antibodies to alglucosidase alfa. Treated patients who experience a decrease in benefit despite continued treatment with Alglucosidase Alfa, in whom antibodies are suspected to play a role, may be tested for neutralization of enzyme uptake or activity.
41 Alkaline Nasal Douche R01A000-999-L50-01-XXX B To remove nasal plug - To be diluted with an equal volume of warm water before use
42 All-Trans Retinoic Acid 10 mg Capsule L01XX14-000-C10-01-XXX A* Acute promyelocytic leukaemia - Induction: 45 mg/m2 daily for 30 - 90 days. Maintenance: 45 mg/m2 daily for 2 weeks every 3 months. Renal/or hepatic insufficiency: 25mg/m2 daily for 30-90 days. Refer to protocols
43 Allopurinol 100 mg Tablet M04AA01-000-T10-02-XXX A/KK i) Frequent and disabling attacks of gouty arthritis (3 or more attacks/year). ii) Clinical or radiographic signs of erosive gouty arthritis. iii) The presence of tophaceous deposits. iii) Urate nephropathy. iv) Urate nephrolithiasis. v) Impending cytotoxic chemotherapy or radiotherapy for lymphoma or leukaemia - Initial dose: 50-100 mg daily. Maintenance: 300-900mg daily (depending on renal function).
44 Allopurinol 300 mg Tablet M04AA01-000-T10-01XXX A/KK i) Frequent and disabling attacks of gouty arthritis (3 or more attacks/year). ii) Clinical or radiographic signs of erosive gouty arthritis. iii) The presence of tophaceous deposits. iv) Urate nephropathy. v) Urate nephrolithiasis. vi) Impending cytotoxic chemotherapy or radiotherapy for lymphoma or leukaemia - Initial dose: 50-100 mg daily. Maintenance: 300-900mg daily (depending on renal function).
45 Alprazolam 0.25 mg Tablet N05BA12-000-T10-01-XXX A/KK Anxiety disorders - 0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children
46 Alprazolam 0.5 mg Tablet N05BA12-000-T10-02-XXX A Anxiety disorders - 0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children
47 Alprazolam 1 mg Tablet N05BA12-000-T10-03-XXX A Anxiety disorders - 0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children
48 Alprostadil 500 mcg/ml Injection C01EA01-000-P30-01-XXX A* For treatment of congenital heart diseases which are ductus arteriosus dependent - 0.05 - 0.1 mcg/kg/min by continuous IV infusion, then decreased to lowest effective dose
49 Alteplase 50 mg per vial Injection B01AD02-000-P40-01-XXX A* Thrombolytic treatment of acute ischaemic stroke. - 0.9 mg/kg (maximum of 90 mg) infused over 60 minutes with 10% of the total dose administered as an initial intravenous bolus. Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging technique.
50 Amantadine HCl 100 mg Capsule N04BB01-110-C10-01-XXX B Parkinson's disease - Initial dose: 100 mg daily and is increased to 100 mg twice daily (not later than 4 p.m.) after a week. Elderly over 65 years: less than 100 mg or 100 mg at intervals of more than 1 day
51 Amikacin 125 mg/ml Injection J01GB06-183-P30-03-XXX A Infections due to susceptible organisms - ADULT: (IM or IV): 15 mg/kg/day 8 - 12 hourly for 7 - 10 days. Maximum: 1.5 g/day. CHILD: 15 mg/kg/day 8 - 12 hourly. Maximum: 1.5 g/day. Neonates: Initial loading dose of 10 mg/kg followed by 7.5 mg/kg/day 12 hourly. Maximum 15mg/kg/day
52 Amikacin 250mg/ml Injection J01GB06-183-P30-02-XXX A Infections due to susceptible organisms - ADULT: (IM or IV): 15 mg/kg/day 8 - 12 hourly for 7 - 10 days. Maximum: 1.5 g/day. CHILD: 15 mg/kg/day 8 - 12 hourly. Maximum: 1.5 g/day. Neonates: Initial loading dose of 10 mg/kg followed by 7.5 mg/kg/day 12 hourly. Maximum 15mg/kg/day
53 Amiloride HCl 5 mg & Hydrochlorothiazide 50 mg Tablet C03EA01-900-T10-01-XXX B i) Diuretic as an adjunct to the management of oedematous states ii) Hypertension - i) Initially 1 - 2 tab daily adjusted according to response. Max : 4 tabs daily. ii) 1 -2 tabs daily as a single or divided dose
54 Amino Acids Injection B05BA01-910-P30-01-XXX A Source of amino acids in patients needing IV nutrition - Dose to be individualised. ADULT usually 500-2000 ml by IV. ADULT usual requirement for amino acid: 1-2 g/kg/day
55 Amino Acids with Electrolytes Injection B05BA10-910-P30-02-XXX A Source of amino acids and electrolytes in patients needing IV nutrition - Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day
56 Amino Acids with Glucose with Electrolytes Injection B05BA10-910-P30-03-XXX A Source of amino acids, carbohydrate and electrolytes in patients needing IV nutrition - Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day, carbohydrate 4-6 g/kg/day
57 Amino Acids, Glucose and Lipid with Electrolytes Injection B05BA10-910-P30-01-XXX A Source of amino acids, carbohydrate, lipid and electrolytes in patients needing IV nutrition - Dose to be individualised. ADULT: 500 - 2000 ml daily given by IV. ADULT usual requirement for amino acid 1-2 g/kg/ day, carbohydrate 4-6 g/kg/day, lipid 2-3 g/kg/day
58 Aminophylline 25 mg/ml Injection R03DA05-000-P30-01-XXX B Reversible airways obstruction, acute severe brochospasm - Adult: Loading dose: 5 mg/kg (ideal body weight) or 250-500 mg (25 mg/ml) by slow inj or infusion over 20-30 min. Maintenance infusion dose: 0.5 mg/kg/hr. Max rate: 25 mg/min. Child: Loading dose: same as adult dose. Maintenance dose: 6 mth-9 yr: 1 mg/kg/hr and 10-16 yr: 0.8 mg/kg/hr.
59 Amiodarone 200 mg Tablet C01BD01-110-T10-01-XXX A* Arrhythmias - 200 mg 3 times daily for 1 week, then reduced to 200 mg twice daily for another week. Maintenance dose, usually 200 mg daily or the minimum required to control the arrhythmia. Dosing is according to product insert / protocol.
60 Amiodarone 50 mg/ml Injection C01BD01-110-P30-01-XXX A* i) Arrhythmias ii) Cardiopulmonary resuscitation of shock-resistant ventricular fibrillation in cardiac arrest - i) Initial: 5mg/kg over 20-120minutes Maintenance: 10-20mg/kg/24hr Max. dose: 1.2g/24hr. ii) Initial: 300mg or 5mg/kg rapid Additional 150mg if condition persists. Dosing is according to product insert / protocol.

Halaman-halaman